# OnCo record paper-xm01-22-tjulandin-arch-drug-inf-2011 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-xm01-22-tjulandin-arch-drug-inf-2011/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-xm01-22-tjulandin-arch-drug-inf-2011" ;
  schema:name "Epoetin theta with a new dosing schedule in anaemic cancer patients receiving nonplatinum-based chemotherapy: a randomised controlled trial (XM01-22)"@en ;
  schema:description "Among people whose chemotherapy had left them anaemic, a weekly epoetin theta injection restored haemoglobin without a transfusion in 73 percent, against 25 percent on placebo, and roughly halved the share who needed a transfusion."@en ;
  schema:url <https://onco.cc/key-papers/paper-xm01-22-tjulandin-arch-drug-inf-2011/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1111/j.1753-5174.2011.00035.x>, <https://pubmed.ncbi.nlm.nih.gov/22022341/>, <https://www.isrctn.com/ISRCTN08063129> ;
  schema:sameAs <https://doi.org/10.1111/j.1753-5174.2011.00035.x> ;
  schema:datePublished "2011"^^xsd:gYear ;
  schema:author "Tjulandin SA, Bias P, Elsässer R, et al." ;
  onco:sections <https://onco.cc/fronts/supportive-care/> ;
  onco:targets <https://onco.cc/targets/epor/> ;
  onco:drugs <https://onco.cc/drugs/epoetin-theta/> ;
  onco:trials <https://onco.cc/trials/xm01-22/> .